Reference : The importance of integrating medication adherence into pharmacoeconomic analyses: the e...
Scientific journals : Article
Business & economic sciences : Special economic topics (health, labor, transportation…)
Human health sciences : Rheumatology
http://hdl.handle.net/2268/115972
The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.
English
Hiligsmann, Mickaël mailto [Université de Liège - ULg > Département des sciences de la santé publique > Département des sciences de la santé publique]
Boonen, Annelies [Maastricht University > Internal Medicine > > >]
Rabenda, Véronique mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé]
REGINSTER, Jean-Yves mailto [Centre Hospitalier Universitaire de Liège - CHU > > Médecine de l'appareil locomoteur]
2012
Expert Reviews of Pharmacoeconomics & Outcomes Research
12
2
159-66
Yes
International
1473-7167
[en] Adherence to medications is poor and suboptimal in many chronic diseases. Nonadherence can reduce treatment effectiveness and can have an impact on healthcare costs. As a consequence, it may alter the cost-effectiveness of drug therapies. This article emphasizes the importance of integrating medication compliance and persistence into pharmacoeconomic evaluations, using osteoporosis as an example. A limited number of studies carried out to date have suggested important economic implications of poor adherence to osteoporosis medications. Therefore, compliance and persistence should be an integral part of clinical studies and pharmacoeconomic analyses in order to estimate the cost-effectiveness of drug therapies in current community practice. Measuring adherence and incorporating it into health economic modeling may, however, pose particular challenges.
http://hdl.handle.net/2268/115972
10.1586/erp.12.8

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
The importance of integrating medication adherence into pharmacoeconomic analysis.pdfPublisher postprint639.17 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.